InsiderTrades

Form 4 for SAM BOSTON BEER CO INC

Accepted 2025-03-04 00:00:00 ET · period of report 2025-03-01 · accession 0001562180-25-001946 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-03-04 2025-03-01 SAM Lysyj Lesya CMO A - Grant $0.00 +6,565 17.2K +62% $0
D 2025-03-04 2025-03-01 SAM Lysyj Lesya CMO F - Tax $243.77 -309 16.9K -2% -$75.3K
DM 2025-03-04 2025-03-01 SAM Lysyj Lesya CMO A - Grant $0.00 +747 725 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common 2025-03-01 A A 6,565 $0.00 17,197 D — — (F2) The shares reported include 10,758 shares of restricted stock subject to vesting conditions.
2 Common Class A Common 2025-03-01 F D 309 $243.77 16,888 D — — (F2) The shares reported include 10,758 shares of restricted stock subject to vesting conditions.
3 Derivative March 1, 2023 Stock Option 2025-03-01 A A 565 $0.00 565 D $323.80 · 2025-03-01 to 2033-02-28 1,697 Class A Common (F5) The Performance-Based Stock Options were granted pursuant to the Issuer's Employee Equity Incentive Plan ("EEIP") on March 1, 2023. The extent to which the options were exercisable was dependent upon the Company achieving certain compounded annual growth rate targets based on net revenue growth in Fiscal Year 2024 over Fiscal Year 2022. In February 2025, the Compensation Committee determined that the performance criteria had been achieved, and as such the options will vest in three equal installments on March 1 in the years 2025-2027, contingent on the Reporting Person's continued employment with the Issuer on the applicable vesting dates.
4 Derivative March 1, 2021 Stock Option 2025-03-01 A A 182 $0.00 725 D $1,028.71 · 2023-03-01 to 2031-02-28 725 Class A Common (F4) The Performance-Based Stock Options were granted pursuant to the Issuer's EEIP on March 1, 2021. The extent to which the options were exercisable was dependent upon the Company achieving certain compounded annual growth rate targets based on net revenue growth in Fiscal Year 2022 over Fiscal Year 2020. In February 2023, the Compensation Committee determined that the performance criteria had been achieved, and as such the options vested in three equal installments on March 1 in the years 2023-2025.